1[1]Jurcic D,Bago J,Eljuga D.Features of uremic neuropathy in longterm dialysis.Coll Antropol,1998,22( 1 ):119-125
2[2]Imam I,Salako BL,Akinola A.Peripheral neuropathy in Nigerian subjects with chronic renal failure.Niger J Med,2003,12(2):72-75
3[3]Man NK,Cueille G,Zingraff J,et al.Uremic neurotoxin in the middle molecular weight range.Artif Organs,1980,4(2):116-120
4[4]Dukanovic L.Middle molecular weight substances and uremic polyneuropathy.Acta Med Iugosl,1990,44(2):117-128
5[5]Avram MM,Feinfeld DA,Huatuco AH.Search for the uremic toxin.Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia.N Engl J Med,1978,298(18):1000-1003
6[6]Aiello I,Serra G,Gilli P,et al.Uremic neuropathy:correlations between electroneurographic parameters and serum levels of parathyroid hormone and aluminum.Eur Neurol,1982,21 (6):396-400
7[7]Barats MS,Gonick HC,Rothenberg S,et al.Severe lead-induced peripheral neuropathy in a dialysis patient.Am J Kidney Dis,2000,35(5):963-968
8[8]Cisari C,Gasco P,Calabrese G,et al.Serum magnesium and nerve conduction velocity in uraemic patients on chronic haemodialysis.Magnes Res,1989,2(4):267-269
